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AbstrAct
Objective
To evaluate the short term associations between 
nitrogen dioxide (NO2) and total, cardiovascular, and 
respiratory mortality across multiple countries/regions 
worldwide, using a uniform analytical protocol.
Design
Two stage, time series approach, with overdispersed 
generalised linear models and multilevel meta-
analysis.
setting
398 cities in 22 low to high income countries/regions.
Main OutcOMe Measures
Daily deaths from total (62.8 million), cardiovascular 
(19.7 million), and respiratory (5.5 million) causes 
between 1973 and 2018.
results
On average, a 10 μg/m3 increase in NO2 concentration 
on lag 1 day (previous day) was associated with 
0.46% (95% confidence interval 0.36% to 0.57%), 
0.37% (0.22% to 0.51%), and 0.47% (0.21% to 
0.72%) increases in total, cardiovascular, and 
respiratory mortality, respectively. These associations 
remained robust after adjusting for co-pollutants 
(particulate matter with aerodynamic diameter ≤10 
μm or ≤2.5 μm (PM10 and PM2.5, respectively), ozone, 
sulfur dioxide, and carbon monoxide). The pooled 
concentration-response curves for all three causes 
were almost linear without discernible thresholds. The 
proportion of deaths attributable to NO2 concentration 
above the counterfactual zero level was 1.23% (95% 
confidence interval 0.96% to 1.51%) across the 398 
cities.
cOnclusiOns
This multilocation study provides key evidence on 
the independent and linear associations between 
short term exposure to NO2 and increased risk of total, 
cardiovascular, and respiratory mortality, suggesting 
that health benefits would be achieved by tightening 
the guidelines and regulatory limits of NO2.
Introduction
Nitrogen dioxide (NO2) is a common air pollutant that 
has adverse effects on population health, is a precursor 
to ground level ozone with its own harmful effects on 
health, and is involved in the secondary formation 
of fine particulate matter. Most ambient NO2 has an 
anthropogenic origin, such as fuel combustion and 
traffic.1 Many studies have reported the effects of 
short term exposure to NO2 on human mortality or 
morbidity,2 3 but these are disputed. The Integrated 
Science Assessment conducted by the United States 
Environmental Protection Agency reviewed the 
existing evidence linking NO2 exposure with health 
outcomes in 20084 and 2016,5 and concluded that 
there is a causal relation between short term exposure 
to NO2 and respiratory effects. The review highlighted 
important gaps in knowledge, resulting in different 
limits for NO2 in air quality guidelines being adop­
ted by various governmental and intergovernmental 
institutions.1 6­8
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WhAt Is AlreAdy knoWn on thIs topIc
Evidence for the short term association between ambient nitrogen dioxide (NO2) 
and mortality is limited, especially for cause specific associations
Previous investigations have been mostly conducted in a small number of 
locations that cover limited geographical areas, and use different study designs 
and modelling approaches that lead to heterogeneous results
WhAt thIs study Adds
This large multilocation study in 398 cities found that each 10 μg/m3 increase in 
NO2 concentrations on lag 1 day (previous day) was significantly associated with 
increased risk of total (0.46%), cardiovascular (0.37%), and respiratory (0.47%) 
mortality
The concentration-response curves were almost linear without discernible 
thresholds even below the current WHO air quality guidelines, suggesting a need 
to revise the currently recommended values
The uniform analytical approach allows a direct comparison of estimates across 
global regions
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Several epidemiological studies have investigated 
the association between NO2 and total mortality,
9 but 
with important limitations. Firstly, most focused on 
total non­accidental deaths, with only a few assessing 
cause specific mortality, such as respiratory and 
cardiovascular outcomes. Moreover, potential features 
of associations between NO2 and mortality, such as 
non­linearity, thresholds, and lag structures, remain to 
be clarified. More importantly, questions remain about 
whether NO2 has an independent effect on mortality, 
or if the observed associations can be explained by 
confounding effects of co­pollutants. Finally, current 
publications mainly include studies performed in single 
cities or countries, with the problem of publication bias 
and difficulties in integrating results from different 
analytical approaches. Furthermore, emissions in 
different contexts, population characteristics, and the 
reliability of routine health data and vital statistics 
limited the generalisability of such evidence.
This study aimed to examine these limitations by 
investigating the short term association between NO2 
and mortality across numerous countries/regions 
worldwide, using data from the Multi­City Multi­
Country Collaborative Research Network (https://
mccstudy.lshtm.ac.uk/). The assessment takes advan­
tage of a uniform analytical framework based on state­
of­the­art epidemiological methodologies to estimate 
flexible exposure­response associations, to integrate 
results across cities and countries, and to quantify 




We obtained health and environmental data from 
the Multi­City Multi­Country database, which has 
been described in previous publications.10 11 Our 
analysis was limited to locations where ground level 
NO2 measurements were available—a total of 398 
cities in 22 countries/regions, with different study 
periods based on data availability. The geographical 
distribution of cities with NO2, and the corresponding 
annual mean concentrations during the study periods 
are shown in eFigure 1. Mortality data were obtained 
from local authorities within each country/region. 
Causes of death were classified according to the 
international classification of diseases, 9th and 10th 
revision (ICD­9 and ICD­10) codes, where available. In 
each location, mortality is represented by daily counts 
of either non­external causes (ICD­9: 0­799; ICD­10: 
A0­R99) or, where not available, all cause mortality. 
We also collected mortality data for two main causes 
in 16 countries: cardiovascular disease (ICD­10, 
codes I00­I99) and respiratory disease (ICD­10, codes 
J00­J99).12
Daily concentrations of particulate matter and other 
gaseous pollutants, including particulate matter with 
aerodynamic diameter ≤10 μm or ≤2.5 μm (PM10 and 
PM2.5, respectively), ozone (O3), sulfur dioxide (SO2), 
and carbon monoxide (CO), were obtained from the 
same fixed site monitoring stations as for NO2, where 
available, to adjust for potential confounding by co­
pollutants. We also collected daily data on weather 
variables, including mean temperature and mean 
relative humidity from local meteorological bureaux 
or other statistical authorities. The overall missing 
rate for all cause mortality, NO2, and temperature 
time series was 0.13%, 4.4%, and 1.2%, respectively. 
Detailed information on missing data is summarised in 
the appendix (eMethod 1.1 and eTable 7).
statistical analysis
The associations of NO2 with daily total, cardiovascular, 
and respiratory mortality were assessed using the 
same analytical protocol in all locations, based on 
extension of a two stage design widely used in previous 
multilocation time series studies.13 14
In the first stage, we estimated the city specific 
associations using a time series quasi­Poisson 
generalised linear regression model featuring a natural 
cubic spline function of time with seven degrees 
of freedom (df) per year to control for unmeasured 
temporal trends and indicators for day of the week. 
Temperature was adjusted using a natural spline 
function with 6 df. Relative humidity was adjusted 
with the same spline function with 3 df in cities where 
such data were available. For the potential lag effect 
of NO2 and temperature, we a priori selected the 
moving average of lag 0­3 days to control temperature 
according to modelling choices of many previous 
studies.14 15 We modelled the association between 
NO2 and mortality using a distributed lag model with 
a linear lag response function, inspecting the lag 
structure on a single lag day of 0 to 3, and moving 
average of the present and previous day (lag 0­1) to 
identify the optimal lag choices.
In the second stage, we used a new multilevel meta­
analytical approach to summarise the city specific 
associations.16 Briefly, this model defines more 
complex random effects structures that account for 
the hierarchical structure of the data—namely, cities 
nested within countries, and provides the best linear 
unbiased predictors for the associations between 
NO2 and mortality at both levels.
16 We computed the 
global, country, and city specific estimates and 95% 
confidence intervals as percentage change in daily 
mortality per 10 μg/m3 increase of NO2 concentrations. 
Potential heterogeneity across cities was assessed with 
Cochran Q tests and I2 statistics. Finally, we computed 
the proportion of deaths attributable to NO2 exposure 
above the counterfactual zero level (since there was no 
obvious threshold level) and presented the population 
attributable fraction (%) at the country level, which 
can be calculated as follows:
RR=exp(â×∆X)
PAF%=(RR−1/RR)×100% 
Where RR is the relative risk of mortality associated 
with NO2 for each country, ∆X is the difference between 
the current annual concentration of NO2 and the 
counterfactual zero level, â is the country specific 
mortality estimate.
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We extended the main models to assess specific 
features of the association. Firstly, we fitted models 
with two pollutants using the other co­pollutants, 
assessing the robustness of the estimates through 
likelihood ratio tests. Countries/regions with unavail­
able data for co­pollutants were excluded accordingly; 
therefore, the number of countries/regions in eTable 
3 varied by co­pollutants. Secondly, we conducted 
regional analyses (eTable 2 and eTable 4) and explored 
potential effect modifiers (such as long term air 
pollution concentrations, temperature, and gross 
domestic product) on the associations between NO2 
and total mortality based on the main models. Finally, 
we explored potential non­linearity in the associations 
and pooled the concentration­response relation curve 
using a meta­smoothing approach applied in previous 
studies,14 17 modelling NO2 as a non­linear term 
through a natural spline function with knots at 20 and 
40 μg/m3.
We conducted several sensitivity analyses to test 
the robustness of our estimates, including alternative 
choices for controlling for temperature, alternative 
placements of knots for testing non­linear exposure­
response between NO2 and mortality, a comparison 
of models with and without adjustment for humidity, 
a test for seasonal differences modelled through 
an interaction with an indicator of warm/cold 
season (May­September v October­April for northern 
hemisphere, and vice versa for southern hemisphere), 
and comparing the associations within different time 
periods with a cutoff point at year 2000 (around the 
median year of each country’s time period).
We conducted all statistical analyses in R software 
(version 3.3.1), using the stats and dlnm packages for 
fitting first stage models and the mixmeta package for 
performing multilevel meta­analyses. We presented 
the percentage change of mortality for a 10 μg/m3 
increase in NO2 concentrations. P values less than 0.05 
were considered statistically significant in all analyses.
Patient and public involvement
This analysis used health data at the aggregated level, 
and thus there is no patient or public involvement. No 
patients were involved in setting the research question 
or the outcome measures, nor were they involved 
in developing plans for recruitment, design, or 
implementation of the study. No patients were asked to 
advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research 
to study participants or relevant patients.
results
Descriptive statistics
This analysis included 62.8 million deaths from 
total or non­external causes, including 19.7 and 5.5 
million deaths from cardiovascular diseases and 
respiratory diseases, respectively (table 1), covering 
the study period from 1973 to 2018. Cardiovascular 
deaths accounted for 31.4% of total deaths among 
all countries, ranging from 19.9% in Thailand to 
50.4% in the Czech Republic; while respiratory deaths 
accounted for 8.8%, ranging from 4.8% in the Czech 
Republic to 15.7% in Japan. On average, the median 
annual mean NO2 concentration across 398 cities was 
26.9 μg/m3 (25th to 75th centiles 19.5 to 36.2 μg/m3), 
which was lower than the air quality guidelines for 
NO2 (annual mean 40 μg/m
3) of the World Health 
Organization.6 The median annual mean temperature 
was 14.4°C (25th to 75th centiles 7.8°C to 20.6°C). 
A detailed summary of exposure data is provided in 
eTable 1. The Spearman correlation coefficients of NO2 
were 0.34 with PM10, 0.38 with PM2.5, −0.24 with O3, 
0.42 with SO2, and 0.56 with CO. On average, NO2 was 
negatively correlated with mean temperature (Pearson 
r=−0.29) and relative humidity (Pearson r=−0.15).
regression results
Figure 1 illustrates the estimated pooled associations 
between NO2 and total, cardiovascular, and respiratory 
mortality on different lag days. Results suggested that 
the magnitude of associations increased from the 
current (lag 0) to the previous day (lag 1) and then 
decreased on lag 2 day for all three endpoints. In 
addition, considering its causal respiratory effect,5 we 
used NO2 concentration on lag 1 day as the main lag 
value for NO2 in subsequent analysis.
Table 2 displays the country specific and pooled 
estimates for the associations of NO2 (lag 1) with 
total, cardiovascular, and respiratory mortality. 
Across 398 cities, a 10 μg/m3 increase in NO2 concen­
trations was associated with an increase of 0.46% 
(95% confidence interval 0.36% to 0.57%) in total 
mortality; while across 362 cities with available 
data, the corresponding increases were 0.37% (95% 
confidence interval 0.22% to 0.51%) and 0.47% (95% 
confidence interval 0.21% to 0.72%), respectively, for 
cardiovascular and respiratory mortality. The country 
specific estimates showed considerable variations. 
Consistently positive associations of NO2 with total 
mortality were seen, ranging from 0.17% to 0.70% for 
total mortality. Estimates were less precise for cause 
specific associations, although generally indicating an 
increased risk.
Figure 2 shows the results of the model with non­
linear terms for estimating the effect of the association 
between NO2 and mortality, indicating positive and 
almost linear concentration­response curves for total, 
cardiovascular, and respiratory mortality, with no 
discernible thresholds. Thus a counterfactual scenario 
at 0 µg/m3 was defined to assess the mortality impacts 
in each country based on the current study sample 
(table 3). Although we recognise that this level is 
not practical from a policy standpoint, our analysis 
provides insight into the overall health burden from 
NO2. The population attributable fraction (%) ranged 
from 0.28% (95% confidence interval 0.05% to 0.51%) 
in Finland and 3.05% (95% confidence interval 
1.79% to 4.29%) in Greece, with a pooled population 
attributable fraction (%) of 1.23% (95% confidence 
interval: 0.96% to 1.51%) across the 398 cities.
In the models with two pollutants (eTable 3), the 
associations of NO2 with total mortality were robust 
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to the adjustment of co­pollutants. The estimates 
of NO2 mortality associations increased slightly 
with adjustment of SO2, O3, and CO. Although the 
effect estimates decreased by 19% (P=0.08) and 
21% (P=0.08) after adjusting for PM10 and PM2.5, 
respectively, the associations were still positive and 
statistically significant.
In the sensitivity analyses, compared with main 
models, the estimates for the associations of NO2 
with mortality were generally similar when adjusting 
for temperature with different lag structures, except 
for a smaller association when using the lag of the 
present and mean of the previous three days (eFigure 
2). The use of alternative knots did not substantially 
change the shape of the concentration­response curves 
(eFigure 3). The associations of NO2 with total and 
cause specific mortality did not change with or without 
adjustment of relative humidity (eTable 5). We found 
no evidence of seasonal difference in the association of 
NO2 with mortality (P=0.68), with the estimate for the 
cold season (0.51%, 95% confidence interval 0.41% 
to 0.60%) similar to that of the warm season (0.43%, 
95% confidence interval 0.31% to 0.50%). Finally, the 
estimates for all three endpoints were nearly the same 
for different time periods (eTable 6).
discussion
Principal findings
A key advantage of this epidemiological study on the 
short term association of NO2 with daily mortality 
is the analysis of a large dataset using the same 
analytical protocol, which allows a valid comparison 
among countries and regions of the world. We found 
robust associations of NO2 with daily mortality 
from total, cardiovascular, and respiratory causes 
that were independent of concomitant exposures to 
other air pollutants. More importantly, we pooled a 
concentration­response curve for NO2 at the global 
level, suggesting an almost linear association, with 
no discernible thresholds. This result suggests that 
NO2 is associated with considerable health risks 
even at levels below health based standards and 
guidelines, including the current WHO air quality 
guidelines.
Among the 398 cities, the risk of total mortality 
increased by 0.46% for every 10 μg/m3 increase in NO2 
concentrations. The magnitude of the association is 
comparable with the result from one previous systema­



























































Fig 1 | relative risks of total, cardiovascular, and respiratory mortality associated with a 
10 μg/m3 increase in nitrogen dioxide (nO2) on different lag days for nO2. lags indicate 
the time difference between the nO2 exposure and the outcome. lag 0=the present 
day; lag 1=the previous day; lag 2=the day before lag 1; lag 3=the day before lag 2; lag 
0-1=the two day moving average of the present day and the previous day





number of deaths (in thousands)* Median (interquartile range)
total cardiovascular respiratory nO2 (μg/m
3) temperature (°c)
Australia 3 1988-2009 1178.0 NA NA 21.4 (14.1-27.9) 18.1 (14.7-21.2)
Brazil 1 1997-2011 916.2 NA NA 84.9 (62.6-115.3) 20.6 (18-22.9)
Canada 25 1986-2015 3617.6 1220.7 307.8 23.7 (15.6-33.8) 7.4 (−0.9-15.7)
Chile 3 2005-13 316.8 NA NA 21.6 (13.9-32.4) 13.7 (10.7-17.2)
China 15 1996-2015 1201.7 468.0 164.7 46.5 (36.2-60.4) 16.3 (6.5-23.5)
Colombia 1 1998-2013 426.3 123.8 46.3 30.5 (23.3-37.9) 13.9 (13.2-14.5)
Czech Republic 1 1994-2015 287.5 145.0 13.9 30.8 (24.2-38.7) 9.2 (2.7-15.3)
Estonia 4 1997-2015 133.8 NA NA 11.4 (7.6-16.7) 6.0 (−0.1-13.6)
Finland 1 1994-2014 153.3 57.4 9.7 6.8 (4.3-11.7) 5.9 (0.0-13.8)
Germany 12 1993-2015 3105.9 NA NA 29.6 (21.8-38.4) 10.5 (4.8-15.9)
Greece 1 2001-10 288 136.2 28.8 50.2 (39.6-61.6) 17.9 (12.9-24.9)
Japan 47 2011-15 1885 496.7 296.0 16.7 (12.1-23.4) 16.1 (7.6-22.7)
Portugal 5 1990-2018 1750.7 659.8 165.9 14.9 (10.0-21.7) 15.4 (11.5-19.9)
Romania 8 1994-2016 951.1 NA NA 25.6 (17.7-36.2) 11.4 (3.4-18.9)
South Korea 7 1992-2015 2245.3 547.5 133.3 43.7 (33.0-57.5) 14.9 (5.7-21.9)
Spain 48 1990-2014 2929.6 1011.8 330.8 26.4 (20.2-33.9) 14.9 (10.2-20.7)
Sweden 1 1990-2010 201.2 91.3 15.9 26.8 (20.0-34.8) 6.8 (1.2-13.9)
Switzerland 8 1995-2013 243.6 90.7 16.0 32.3 (24.0-42.0) 10.7 (4.4-16.5)
Taiwan 3 1994-2014 1209.6 269.4 116.5 42.2 (31.6-54.7) 24.9 (20.4-28.0)
Thailand 18 1999-2008 843.4 167.8 110.2 22.0 (16.3-30.4) 28.0 (26.4-29)
United Kingdom 39 1990-2016 5413.4 1978.9 799.2 25.6 (17.9-35.6) 10.4 (6.6-14.7)
United States 147 1973-2006 33 502.8 12 303.5 2904.9 28.7 (20.8-38.6) 14.7 (7.2-21.8)
Pooled 398 1973-2018 62 800.8 19 768.5 5459.9 26.9 (19.5-36.2) 14.4 (7.8-20.6)
NO2=nitrogen dioxide; NA=not available.
*Mortality data from cardiovascular and respiratory diseases were not available in Australia, Brazil, Chile, Estonia, Germany, and Romania.
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wide and reported an estimate of 0.78% for all cause 
mortality with the same NO2 increment as ours.
18 The 
other multilocation study conducted in Europe (known 
as the Air Pollution on Health: a European Approach 
(APHEA)2 project) found a smaller effect estimate with 
an increase of 0.30% (95% confidence interval 0.22% 
to 0.38%) in all cause mortality associated with a 10 
μg/m3 increase in NO2.
19 Our estimate is somewhat 
smaller than some multilocation studies conducted 
in a single country. For a 10 μg/m3 increase in NO2, a 
multilocation study in China observed a 0.91% (95% 
confidence interval 0.70% to 1.12%) increase in total 
mortality20; another study in Italy reported an estimate 
of 2.09% (95% confidence interval 0.96% to 3.24%).21 
The differences in estimates do not necessarily reflect a 
diverse effect of NO2 on health. Rather, the coverage of 
regions and time periods, population characteristics, 
and exposure patterns might contribute to these 
various findings. Furthermore, as found in our 
sensitivity analysis, different modelling specification 
for temperature would introduce fluctuation in the 
estimated associations.
The 2016 Integrated Science Assessment conducted 
by the US Environmental Protection Agency determined 
a causal relation between short term NO2 exposure and 
respiratory effects, whereas for total mortality and 
cardiovascular effects, the conclusion was “suggestive 
of, but not sufficient to infer, a causal relation.” Our 
findings from this multilocation analysis add to the 
supporting evidence for causal associations between 
short term exposure to NO2 and non­respiratory 
endpoints. Experimental investigations and controlled 
human exposure studies are needed to understand the 
non­respiratory effect of NO2.
There has been a long debate on whether exposure 
to NO2 independently causes health effects, or 
whether it serves as a marker for a broader mixture 
of air pollutants, especially those related to traffic.5 
Findings from controlled human exposure and 
animal toxicological studies are scarce, but are key 
for indicating independent associations.22 23 Although 
statistically adjusting the NO2 association for another 
co­pollutant cannot conclusively show an independent 
effect, gathering evidence might contribute towards 
understanding this matter. In our analysis, the NO2­
mortality association decreased after adjustment of 
PM10 and PM2.5 but remained positive and statistically 
significant. A systematic review, including studies in 
26 cities worldwide, found similarly that the effect 
estimates of NO2 on total mortality decreased from 
0.78% to 0.60%, but were still statistically significant 
after adjusting for PM.18 Meanwhile, as found in our 
previous study, the association between PM and 
mortality was also influenced by NO2.
15 This association 
might indicate potential mutual confounding in the 
PM­mortality and NO2­mortality associations. On 
the other hand, the null estimates found in previous 
reports of NO2 after adjustment of co­pollutants might 
be due to the smaller study sample, regional difference, 
and other uncertainties of study heterogeneity. Our 
multilocation study and meta­analysis provided robust 
evidence for the independent association between NO2 
and mortality.
Characterising the shape of the concentration­
response curve helps to quantify the effect on 
public health of exposure to NO2 and establish safe 
concentration limits. The shape of the concentration­
response curve between effect on health and short term 
table 2 | Percentage changes in total, cardiovascular, and respiratory mortality associated with increase of 10 μg/m3 in nitrogen dioxide on lag 1 day. 
results are shown as percentage (95% confidence interval)
country/region
total mortality cardiovascular mortality respiratory mortality
no* Mean change (%; 95% ci) no* Mean change (%; 95% ci) no* Mean change (%; 95% ci)
Australia 3 0.64 (0.36 to 0.93) 0 NA 0 NA
Brazil 1 0.34 (0.22 to 0.47) 0 NA 0 NA
Canada 25 0.62 (0.47 to 0.76) 24 0.45 (0.23 to 0.67) 24 0.52 (0.10 to 0.94)
Chile 3 0.53 (0.39 to 0.67) 0 NA 0 NA
China 15 0.57 (0.31 to 0.83) 13 0.54 (0.34 to 0.73) 13 0.76 (0.41 to 1.12)
Colombia 1 0.31 (0.01 to 0.61) 1 0.28 (−0.09 to 0.66) 1 −0.05 (−0.75 to 0.67)
Czech Republic 1 0.46 (0.16 to 0.76) 1 0.37 (0.01 to 0.73) 1 0.42 (−0.34 to 1.18)
Estonia 4 0.40 (0.06 to 0.74) 0 NA 0 NA
Finland 1 0.41 (0.08 to 0.75) 1 0.39 (−0.01 to 0.79) 1 0.50 (−0.27 to 1.28)
Germany 12 0.62 (0.47 to 0.78) 0 NA 0 NA
Greece 1 0.62 (0.36 to 0.88) 1 0.47 (0.15 to 0.80) 1 0.84 (0.20 to 1.49)
Japan 47 0.36 (0.19 to 0.54) 47 0.18 (−0.10 to 0.45) 47 0.70 (0.27 to 1.12)
Portugal 5 0.52 (0.37 to 0.66) 5 0.22 (−0.07 to 0.51) 5 0.13 (−0.40 to 0.66)
Romania 8 0.27 (0.07 to 0.48) 0 NA 0 NA
South Korea 7 0.41 (0.12 to 0.70) 7 0.48 (0.25 to 0.71) 7 0.48 (0.05 to 0.91)
Spain 48 0.70 (0.51 to 0.88) 47 0.53 (0.25 to 0.81) 47 0.88 (0.40 to 1.35)
Sweden 1 0.55 (0.27 to 0.83) 1 0.21 (−0.16 to 0.59) 1 0.41 (−0.34 to 1.15)
Switzerland 8 0.24 (−0.07 to 0.55) 8 0.52 (0.16 to 0.88) 8 0.24 (−0.47 to 0.96)
Taiwan 3 0.52 (0.28 to 0.76) 3 0.37 (0.07 to 0.67) 3 0.22 (−0.29 to 0.74)
Thailand 18 0.32 (0.13 to 0.51) 18 0.38 (0.03 to 0.74) 18 0.69 (0.10 to 1.28)
United Kingdom 39 0.17 (0.04 to 0.30) 39 0.10 (−0.09 to 0.28) 39 0.11 (−0.21 to 0.43)
United States 147 0.57 (0.46 to 0.68) 146 0.45 (0.30 to 0.61) 146 0.62 (0.34 to 0.90)
Pooled 398 0.46 (0.36 to 0.57) 362 0.37 (0.22 to 0.51) 362 0.47 (0.21 to 0.72)
NA=not available.
*Number of cities with available data within the country or region.
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exposure to NO2, however, has only been examined in 
a small number of epidemiologic studies with a limited 
spatial scale. Our study provides pooled estimates 
of the concentration­response relation curves for 
short term exposure to NO2 and total, cardiovascular, 
and respiratory mortality across various cities and 
countries. Results show that the curves are almost 
linear with no obvious thresholds, suggesting that the 
level of NO2 below the current air quality guidelines 
is still hazardous to public health. We estimated that 
reduction in daily NO2 concentration to a counterfactual 
zero level would reduce 1.25% of attributable deaths 
across the 398 cities. Although reduction of NO2 to 
zero is infeasible, our analysis provides insight into 
the public health benefits of substantial reductions 
in NO2, suggesting considerable health benefits from 
stricter control of NO2 emissions and tightening of the 
regulatory limits of NO2 in future revisions of WHO air 
quality guidelines.
strengths and limitations of the study
This multilocation study has several advantages. 
Firstly, the study included 398 cities of 22 countries, 
providing enormous statistical power and ensuring 
the stability of the findings. Secondly, we examined 
the associations of NO2 with not only total, but 
also cause specific, mortality. Thirdly, we pooled 
concentration­response curves covering a wide range 
of ambient NO2 concentrations, the evidence from 
which can be considered generalisable. Fourthly, the 
uniform analytical approaches can aid in integrating 
and comparing the results across different regions 
and populations. Finally, our results contribute to the 
increasing evidence that supports independent health 
effects of NO2 on total, cardiovascular, and respiratory 
mortality.
We acknowledge some limitations of this study. 
Firstly, given the vast difference in accessibility, most 
of the data on health and exposure were obtained from 
developed areas, such as Europe, North America, and 
East Asia. Thus global generalisation of the findings 
should be interpreted with caution, especially for areas 
with smaller study samples or none (that is, Africa and 
Latin America). 
Secondly, this analysis was inherently a time series 
design that used ecological data and environmental 
measurements from fixed site monitors, and we could 
not completely rule out ecological fallacy and exposure 
misclassification. In addition, the assumption of 
this time series study is that the reconstructed daily 
levels of air pollution are a good representation of 
the average exposure across the whole population at 
the city level.24 25 Under this condition, the estimates 
of aggregated analyses are affected by Berkson’s bias 
and not measurement error bias, leading therefore to 
the correct point estimates and only an inflation of the 
standard errors.26 27 Therefore, although the proximity 
of people to air quality monitors is unclear, the overall 
results would not be substantially biased. 
Thirdly, there might have been slight changes in 
air pollution measurements in this multilocation 
study covering multiple decades, and the health data 
collection might be subject to diagnostic or coding 
errors. The effects of these problems on our results 
are difficult to evaluate, adding more uncertainty to 
cause specific mortality than to all cause mortality. 
The internal validity of each location specific dataset 
is presumed to be high, however, in that the changes 
in operating protocols, diagnostic practices, and 
coding have been accounted for by the statisti­
cal authorities in the various data gathering and 
preparation stages. 
Fourthly, health outcomes were obtained only from 
their primary causes, and thus our analysis might 
underestimate the potential effect of NO2 on total 
mortality. Finally, missing data were inevitable in such 
a multilocation study over a long period of time, but 
the amount of missing data was generally small for 
both health and exposure data, and its influence on 
our estimates is unlikely to be substantial (Appendix, 
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Fig 2 | concentration-response curve between nitrogen dioxide (nO2) concentrations 
(lag 1) and total, cardiovascular, and respiratory mortality. the vertical scale can be 
interpreted as the relative change of the mean effect of nO2 on mortality; the fraction of 
the curve below zero denotes a smaller estimate than the mean effect
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conclusions and policy implications
In summary, this multilocation time series analysis 
provides robust evidence for the independent asso­
ciations of short term exposure to NO2 with increased 
risk of total, cardiovascular, and respiratory mortality, 
although the total mortality burden might be 
underestimated as the study locations did not fully 
reach global coverage. The associations remained 
positive and statistically significant after adjusting 
for co­pollutants. The concentration­response curves 
were linear without discernible thresholds, suggesting 
a need to revise and tighten the current air quality 
guidelines of NO2 for greater public health benefit, 
and to consider a regulation limit for daily mean NO2 
concentration. These findings contribute to a better 
understanding of how to optimise public health 
actions and strategies to mitigate air pollution.
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